Indication

Mycosis fungoides

Mycosis fungoides is an extranodal non-Hodgkin lymphoma and the most common form of primary cutaneous T-cell lymphoma. Read more about Mycosis fungoides

421 drugs 196 manufacturers

Advertisement

Drugs that treat it

Common Mycosis fungoides therapies.

Showing 379–387 of 421 drugs

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
INTERSTELLAR PH

PREDNISOLONE

GLUCOCORTICOSTEROIDS·TRICHINOSIS·+59
Avet Pharmaceuticals

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES·RETINOBLASTOMA·+17
EPIC PHARMA LLC

DEXAMETHASONE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
ADVAGEN PHARMA

DEXAMETHASONE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
KANCHAN HEALTHC
Filter & compare in the drug finder →Opens the drug finder with Mycosis fungoides preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Mycosis fungoides.

Mycosis fungoides is an extranodal non-Hodgkin lymphoma and the most common form of primary cutaneous T-cell lymphoma.

It predominantly affects adults—most frequently presenting in older individuals—and arises from the malignant proliferation and epidermotropism of mature skin-homing memory T lymphocytes.

The disease characteristically exhibits an indolent clinical course that evolves through distinct cutaneous stages, progressing from persistent erythematous patches to infiltrated plaques, and potentially to cutaneous tumors, generalized erythroderma, or systemic dissemination to lymph nodes and visceral organs.

Personalize your experience

Follow Mycosis fungoides and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it